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Abstract 
 
This report describes the production of ERM-AC051, benzo[a]pyrene, ERM-AC053, indeno[1,2,3-cd]pyrene and ERM-AC082, 6-methylchrysene, which are 
pure materials certified for their purity. This material was produced following ISO Guide 34:2009 and is certified in accordance with ISO Guide 35:2017. 
The materials were custom synthesized, purified and filled into glass vials. 
Between unit-homogeneity was quantified and stability during dispatch and storage were assessed in accordance with ISO Guide 35:2017. 
The material was characterised by applying different methods (HPLC, GC, DSC, qNMR, ICP-MS) in different laboratories of demonstrated competence and 
adhering to ISO/IEC 17025.  
Uncertainties of the certified values were calculated in accordance with the Guide to the Expression of Uncertainty in Measurement (GUM) and include 
uncertainties related to possible inhomogeneity, instability and characterisation. 
The main purpose of the material is for preparation of calibrant solutions. As any reference material, it can also be used for control charts or validation 
studies. 
The CRMs are available in amber glass vials containing at least 25 mg powder which were sealed. The minimum amount of sample to be used is 1 mg. 
 
 
 
 
 
 
  
 
 
CERTIFICATION REPORT 
 
 
The certification  
the purity of three PAHs, benzo[a]pyrene (ERM®-AC051),  
indeno[1,2,3-cd]pyrene (ERM®-AC053) and  
6-methylchrysene (ERM®-AC082) 
 
 
A. Held, T.P.J. Linsinger 
 
 
 
 
 
 
European Commission, Joint Research Centre 
Directorate F – Health, Consumers and Reference Materials 
Geel, Belgium 
 
 
 
 
 
 
 Disclaimer 
 
Certain commercial equipment, instruments, and materials are identified in this paper to specify adequately the 
experimental procedure. In no case does such identification imply recommendation or endorsement by the 
European Commission, nor does it imply that the material or equipment is necessarily the best available for the 
purpose.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 
Summary 
This report describes the production of ERM-AC051, benzo[a]pyrene, ERM-AC053, 
indeno[1,2,3-cd]pyrene and ERM-AC082, 6-methylchrysene, which are pure materials 
certified for their purity. This material was produced following ISO Guide 34:2009 [1] and is 
certified in accordance with ISO Guide 35:2017 [2]. 
The materials were custom synthesized, purified and filled into glass vials. 
Between unit-homogeneity was quantified and stability during dispatch and storage were 
assessed in accordance with ISO Guide 35:2017 [2]. 
The material was characterised by applying different methods (HPLC, GC, DSC, qNMR, ICP-
MS) in different laboratories of demonstrated competence and adhering to ISO/IEC 17025.  
Uncertainties of the certified values were calculated in accordance with the Guide to the 
Expression of Uncertainty in Measurement (GUM) [3] and include uncertainties related to 
possible inhomogeneity, instability and characterisation. 
The main purpose of the material is for preparation of calibrant solutions. As any reference 
material, it can also be used for control charts or validation studies. 
The CRMs are available in amber glass vials containing at least 25 mg powder which were 
sealed. The minimum amount of sample to be used is 1 mg. 
The following values were assigned: 
 
 Mass fraction  
Certified value 1) 
[g/g] 
Uncertainty 2) 
[g/g] 
ERM-AC051, benzo[a]pyrene 
ERM-AC053, indeno[1,2,3-cd]pyrene 
 
ERM-AC082, 6-methylchrysene 
0.979 
0.996 
 
0.983 
0.007 
+ 0.004 
- 0.005 3) 
0.005 
1) Calculated as combination of the sum of impurities as detected by different methods subtracted from 
unity and quantitative nuclear magnetic resonance. The certified values and their uncertainties are 
traceable to the SI. 
2) Expanded uncertainty with a coverage factor k = 2 according to the Guide for the Expression of 
Uncertainty in Measurement, corresponding to a level of confidence of about 95 %. 
3) The asymmetric uncertainty interval is based on a standard uncertainty of 0.0022 g/g. 
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Glossary 
m∆  Absolute difference between the mean measured value and the certified 
value of a CRM 
ANOVA Analysis of variance 
BCR Community Bureau of Reference, the former reference materials 
programme of the European Commission 
CDCl3 Deuterochloroform 
CRM Certified reference material 
DMSO Dimethylsulfoxide 
DSC Differential scanning calorimetry 
EPA Environmental Protecion Agency of the USA 
FID Flame ionization detection 
GC Gas chromatography 
GC-FID Gas chromatography with flame ionization detection 
GCxGC Comprehensive two-dimensional gas chromatography 
GC-MS Gas chromatography with mass spectrometric detection 
GMP Good Manufacturing Practice 
HPLC-UV High performance liquid chromatography with ultra-violet detection 
ICP-MS Inductively coupled plasma mass spectrometry 
ICP-OES Inductively coupled plasma optical emission spectrometry 
JRC Joint Research Centre of the European Commission 
k  
LOD 
Coverage factor 
Limit of detection 
MS Mass spectrometry 
MSamong Mean square among bottles from an ANOVA 
MSwithin Mean square within a bottle from an ANOVA 
n Average number of replicates per bottle 
PAH Polycyclic hydrocarbon 
qNMR Quantitative nuclear magnetic resonance spectroscopy 
RSDstab Relative standard deviation of all results of the stability study 
RSDmethod Method repeatability, expressed as relative standard deviation 
sbb Between-unit variability, expressed as relative standard deviation; an 
additional index "rel" is added as appropriate 
swb Within-unit standard deviation; an additional index "rel" is added as 
appropriate 
SI International System of Units (Système International d'Unités) 
u Standard uncertainty 
u∆ Combined uncertainty of m∆  
U∆ Expanded uncertainty of m∆  
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ubb Uncertainty related to a possible between-bottle heterogeneity; an 
additional "rel" is added to denominate relative uncertainties 
u*bb Uncertainty of heterogeneity that could be hidden by method 
repeatability, expressed as relative uncertainty 
uchar Uncertainty of the characterisation; an additional "rel" is added to 
denominate relative uncertainties 
uCRM Combined uncertainty of a certified value 
UCRM Expanded uncertainty of a certified value; an additional "rel" is added to 
denominate relative uncertainties 
ults Uncertainty of stability; an additional "rel" is added to denominate relative 
uncertainties 
um Measurement uncertainty 
x Pre-defined shelf life 
x  Average of all time points in an isochronous stability study 
xi Time point i  in an isochronous stability study 
y  Average of all results of a homogeneity study 
νMSwithin Degrees of freedom of MSwithin 
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1 Introduction  
1.1 Background 
Accurate measurements of polycyclic hydrocarbons (PAHs) are required by legislation in a 
number of matrices, amongst other food (Commission Regulation (EC) No. 208/2005 [4] 
amending Regulation (EC) No. 466/2001 [5], Directive 2005/10/EC and Commission 
Recommendation 2005/108/EC) and environmental samples (Air Quality Framework 
Directive 96/62/EC [6] and Daughter Directive 2004/107/EC [7], the Water Framework 
Directive 2000/60/EC [8] etc.). Any of these measurements require the availability of reliable 
calibrants. For many years, the European Commission's reference materials programme has 
been supplying these PAH calibrants as solid pure substances, amongst many other BCR-
051R (benzo[a]pyrene), BCR-053 (indeno[1,2,3-cd]pyrene) and BCR-082R (6-
methylchrysene). After the stock of these three PAHs was exhausted the Reference 
Materials Unit of the Directorate F of the European Commission's Joint Research Centre 
decided to produce new batches, labelled ERM-AC051, ERM-AC053 and ERM-AC082, and 
subsequently certified. 
 
 
 
a) Benzo[a]pyrene 
 
 
b) Indeno[1,2,3-cd]pyrene  c) 6-Methylchrysene 
Figure 1: Structural formulas of the three PAHs.  
a) Benzo[a]pyrene, CAS no. 50-32-8, molecular mass: 252.32 g/mol   
b) Indeno[1,2,3-cd]pyrene, CAS no. 193-39-5, molecular mass: 276.34 g/mol  
c) 6-Methylchrysene, CAS no. 1705-85-7, molecular mass: 242.33 g/mol 
1.2 Design of the CRM project 
The basic goal of the project was to obtain materials of a purity above 95 %. In this case 
impurities expressed in molar fraction, mass fraction and response fraction (chromatographic 
area percent) can be assumed to be roughly equivalent, as even response factors differing 
by an order of magnitude will not have a large impact on the final assessment of purity. If this 
is ensured, results from different methods can be combined even if they contain unidentified 
impurities. 
During characterisation different methods were applied to be able to detect all impurities 
potentially present, including inorganic impurities, detected by inductively-coupled plasma 
mass spectrometry or optical emission spectrometry (ICP-MS or ICP-OES), organic 
impurities, detected by high-performance liquid chromatography (HPLC), gas 
chromatography (GC) and quantitative nuclear magnetic resonance (qNMR) as well as 
differential scanning calorimetry (DSC). 
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2 Participants 
2.1 Project management and evaluation 
European Commission, Joint Research Centre, Directorate F – Health, Consumers and 
Reference Materials, Geel, BE  
(accredited to ISO Guide 34 for production of certified reference materials, BELAC No. 268-RM) 
2.2 Processing  
Biochemisches Institut für Umweltcarcinogene, Prof. Dr. Gernot Grimmer-Foundation (BIU), 
Grosshansdorf, DE 
Vlaamse Instelling voor Technologisch Onderzoek (VITO), Mol, BE 
2.3 Homogeneity and stability study 
European Commission, Joint Research Centre, Directorate F – Health, Consumers and 
Reference Materials, Geel, BE 
2.4 Characterisation 
Biochemisches Institut für Umweltcarcinogene, Prof. Dr. Gernot Grimmer-Foundation (BIU), 
Grosshansdorf, DE 
Bundesanstalt für Materialforschung und –prüfung (BAM), Berlin, DE  
(measurements under the scope of ISO/IEC 17025 accreditation DAP-PL-2614.14) 
European Commission, Joint Research Centre, Directorate F – Health, Consumers and 
Reference Materials, Geel, BE 
European Directorate for the Quality of Medicines (EDQM), Strasbourg, FR 
LGC Ltd, Teddington, UK  
(measurements under the scope of ISO/IEC 17025 accreditation UKAS 0423) 
Spectral Service, Cologne, DE  
(certified for GMP; City Government of Cologne, CGN/24.30.12-P/01/2018/043)  
Vlaamse Instelling voor Technologisch Onderzoek (VITO), Mol, BE 
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3 Material processing and process control 
The three PAHs, namely benzo[a]pyrene (ERM-AC051), indeno[1,2,3-cd]pyrene (ERM-
AC053) and 6-methylchrysene (ERM-AC082) were synthesized on demand for this project. 
After an initial check of the purity at the JRC, the PAHs were manually weighed into the pre-
cleaned brown glass vials in a glove box flushed with argon at VITO. At least 25 mg were 
filled into each vial, typically they contain between 26 and 30 mg of PAH. After filling and 
capping the vials were wiped twice using a paper tissue wetted with methanol to remove any 
residues on the outside. Every vial was labelled individually with a label containing the CRM 
identification, hazard labels and its number in the filling sequence. A flow chart of the 
processing is shown in Figure 2. 
 
 
Figure 2: Processing of the three PAH CRMs 
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4 Homogeneity 
A key requirement for any reference material aliquoted into vials is equivalence between 
those vials. In this respect, it is relevant whether the variation between vials is significant 
compared to the uncertainty of the certified value, but it is not relevant if this variation 
between vials is significant compared to the analytical variation. Consequently, ISO Guide 34 
[1] requires RM producers to quantify the between vial variation. This aspect is covered in 
between-vial homogeneity studies. 
The within-vial inhomogeneity does not influence the uncertainty of the certified value when 
the minimum sample intake is respected, but determines the minimum size of an aliquot that 
is representative for the whole vial.  
4.1 Between-vial homogeneity 
The between-vial homogeneity was evaluated to ensure that the certified values of the CRMs 
are valid for all vials of the material, within the stated uncertainties. 
The number of vials selected corresponds to approximately the cube root of the total number 
of vials produced. For ERM-AC051, 15 vials were selected whereas 10 vials were used for 
ERM-AC053 and ERM-AC082. The vials were selected using a random stratified sampling 
scheme covering the whole batch for the between-vial homogeneity test. For this, the batch 
was divided into groups with equal number of vials per group and one vial was selected 
randomly from each group. Independent samples were taken from each selected vial, and 
analysed by differential scanning calorimetry (DSC). Triplicate analyses were performed on 
each vial of ERM-AC051 and duplicate analysis for each vial of ERM-AC053 and ERM-
AC082. The results of the homogeneity study are shown in Annex A. 
Regression analyses were performed to evaluate potential trends in the filling sequence. No 
trends in the filling sequence or the analytical sequence were observed at a 95 % confidence 
level. The datasets were assessed for consistency using Grubbs outlier tests at a confidence 
level of 99 % on the individual results and on the vial means.  
Quantification of between-vial inhomogeneity was undertaken by analysis of variance 
(ANOVA), which separates the (relative) between-vial variation (sbb,rel) from the (relative) 
within-vial variation (swb,rel). The latter is equivalent to the method repeatability if the individual 
samples were representative for the whole vial.  
Evaluation by ANOVA requires mean values per vial, which follow at least a unimodal 
distribution and results for each vial that follow unimodal distributions with approximately the 
same standard deviations. The distribution of the mean values per vial was visually tested 
using histograms and normal probability plots. The results of all statistical evaluations are 
given in Table 1.  
Table 1: Results of the statistical evaluation of the homogeneity studies. Outliers were 
tested on a 99 % confidence level, trends at a 95 % confidence level. 
Material Trends in the filling 
sequence  
Outliers 
 
Distribution of 
vial means 
ERM-AC051 no no normal 
ERM-AC053 no no normal 
ERM-AC082 no no normal 
 
It should be noted that sbb,rel and swb,rel are estimates of the true standard deviations and are 
therefore subject to random fluctuations. Therefore, the mean square between groups 
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(MSamong) can be smaller than the mean squares within groups (MSwithin), resulting in negative 
arguments under the square root used for the estimation of the between-vial variation, 
whereas the true variation cannot be lower than zero. In this case, u*bb, the maximum 
inhomogeneity that could be hidden by method repeatability, was calculated as described by 
Linsinger et al. [9]. u*bb is comparable to the LOD of an analytical method, yielding the 
maximum inhomogeneity that might be undetected by the given study setup.  
Method repeatability (swb,rel), between–vial standard deviation (sbb,rel) and u*bb,rel were 
calculated as:  
, = 	
  Equation 1 
, =



   Equation 2 
∗ =

  


  Equation 3 
MSwithin mean of squares within-vial from an ANOVA  
MSamong mean of squares between-vial from an ANOVA 
y  mean of all results of the homogeneity study 
n mean number of replicates per vial 
MSwithinν  degrees of freedom of MSwithin  
 
The results of the evaluation of the between-vial variation are summarised in Table 2. The 
resulting values from the above equations was/were converted into relative uncertainties.  
 
Table 2: Results of the homogeneity studies 
CRM  
sbb,rel 
[%]
 
u*bb,rel 
[%] 
ubb,rel 
[%] 
ERM-AC051 n.c.1) 0.002 0.002 
ERM-AC053 0.061 0.048 0.061 
ERM-AC082 n.c.1) 0.028 0.028 
1)
 n.c.: cannot be calculated as MSamong < MSwithin 
When comparing the purity as determined by DSC with the purity obtained by other methods 
and the certified purity (see section 6) it is obvious that DSC overestimates the purity in case 
of ERM-AC051 and ERM-AC082. DSC cannot detect impurities that form solid solutions with 
the main component. Any heterogeneity originating from such impurities would therefore not 
be detected using this method and the uncertainty contribution of homogeneity would be 
underestimated. The uncertainty contribution of homogeneity is small compared to other 
sources of uncertainty for all materials. Even if it was larger, it would not significantly affect 
the uncertainty of the certified value (see section 7). Therefore, no additional efforts were 
made to further investigate the homogeneity. This is further confirmed by the good within-
laboratory reproducibility observed in the characterisation of the materials. 
The homogeneity study showed no outlying vial means or trends in the filling sequence. 
Therefore the between-vial standard deviation can be used as estimate of ubb. As u*bb sets 
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the limits of the study to detect inhomogeneity, the larger value of sbb and u*bb is adopted as 
uncertainty contribution to account for potential inhomogeneity. 
4.2 Within-vial homogeneity and minimum sample intake 
The within-vial homogeneity is closely correlated to the minimum sample intake. The 
minimum sample intake is the minimum amount of sample that is representative for the 
whole vial and thus should be used in an analysis. Using sample sizes equal or above the 
minimum sample intake guarantees the certified value within its stated uncertainty.  
Despite the differences observed between the different methods applied for the purity 
determinations (see section 6) all measurements very good precision. As the laboratories 
applying the mass balance approach carried out determinations on 6 different subsamples of 
two different vials, this can be considered good evidence that the sample intakes used by the 
laboratories were sufficient. Typically, sample intakes of 0.25 - 5 mg have been used. Further 
the homogeneity data by differential scanning calorimetry (DSC) has been obtained on 1.16 
– 1.80 mg subsamples. Summarising these findings, a minimum sample intake of 1 mg is 
established for the CRMs. Users will need to consider the uncertainty of their weighings 
when using such small sample intakes. 
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5 Stability 
Time, temperature, light (including ultraviolet radiation) and water content were regarded as 
the most relevant influences on the stability of the materials. The influence of ultraviolet or 
visible light was minimised by storing the material in containers which reduces light 
exposure. In addition, materials are stored in the dark and dispatched in boxes, thus 
removing any possibility of degradation by light. The water content was adjusted to an 
optimum during processing 
Stability testing is necessary to establish the conditions for storage (long-term stability) as 
well as the conditions for dispatch of the materials to the customers (short-term stability). 
During transport, especially in summer time, temperatures up to +60 °C can be reached and 
stability under these conditions must be demonstrated, if the samples are to be transported 
without any additional cooling. 
The stability studies were carried out using an isochronous design [10]. In this approach, 
samples were stored for a particular length of time at different temperature conditions. 
Afterwards, the samples were moved to conditions where further degradation can be 
assumed to be negligible (reference conditions). At the end of the isochronous storage, the 
samples were analysed simultaneously under repeatability conditions. Analysis of the 
material (after various exposure times and temperatures) under repeatability conditions 
greatly improves the sensitivity of the stability tests.  
5.1 Short-term stability study 
For the short-term stability study, samples were stored at +18 °C and +60 °C for 0, 1, 2 and 4 
weeks (at each temperature). The reference temperature was set to -20 °C. Two vials of 
ERM-AC051 and ERM-AC053 and 4 vials of ERM-AC082 per storage time were selected 
using a random stratified sampling scheme. From each vial, two samples were measured by 
DSC. The measurements were performed under repeatability conditions. The results of the 
short-term stability study are shown in Annex B. 
The data were evaluated individually for each temperature. The results were screened for 
outliers using the single and double Grubbs test on a confidence level of 99 %. One outlying 
individual result for t=0 was found for ERM-AC051 (Table 3). As no technical reason for the 
outliers could be found all data were retained for statistical analysis.  
In addition, the data were evaluated against storage time, and regression lines of mol fraction 
versus time were calculated, to test for potential increases/decrease of the purity due to 
shipping conditions. The slopes of the regression lines were tested for statistical significance. 
None of the trends was statistically significant at a 95 % confidence level for any of the 
temperatures.  
The results of the measurements are shown in Annex B. The results of the statistical 
evaluation of the short-term stability are summarised in Table 3.  
Table 3: Results of the short-term stability tests. The outliers of ERM-AC051 were retained.  
CRM Number of individual outlying 
results on a 99 % confidence 
level 
Significance of the trend on a 
95 % confidence level 
18 ºC 60 ºC 18 ºC 60 ºC 
ERM-AC051 1 1 no no 
ERM-AC053 0 0 no no 
ERM-AC082 0 0 no no 
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Two statistical outliers were detected for ERM-AC051 and they were retained for the 
estimation of uSTS. None of the trends was statistically significant on a 95 % confidence level 
for any of the temperatures. 
The material is stable at +18°C and +60°C for up to 4 weeks. The samples can be safely 
dispatched under conditions where the temperatures do not exceed +60 °C for up to 4 
weeks, i.e. at ambient temperature. 
5.2 Long-term stability study 
For the long-term stability study, samples were stored at +4 °C for 0, 4, 8 and 12 months. 
The reference temperature was set to -20 °C. Three vials per storage time were selected 
using a random stratified sampling scheme. From each vial, two samples were measured by 
DSC. The measurements were performed under repeatability conditions.  The results of the 
short-term stability study are shown in Annex C. 
The long-term stability data were evaluated individually for each temperature. The results 
were screened for outliers using the single and double Grubbs test at a confidence level of 
99 %. Some outlying individual results were found (Table 4). As no technical reason for the 
outliers could be found all data were retained for statistical analysis.  
In addition, the data were plotted against storage time and linear regression lines of mole 
fraction versus time were calculated. The slopes of the regression lines were tested for 
statistical significance (loss/increase due to storage). No significant trend was detected at a 
95 % confidence level. 
The results of the long-term stability measurements are shown in Annex C. The results of the 
statistical evaluation of the long-term stability study are summarised in Table 4.  
Table 4: Results of the long-term stability tests. All outliers were retained.  
CRM Number of individual outlying 
results on a 99 % confidence 
level 
Significance of the trend on 
a 95 % confidence level 
ERM-AC051 1 no 
ERM-AC053 0 no 
ERM-AC082 2 no 
 
None of the trends was statistically significant on a 99 % confidence level for any of the 
temperatures. The material can therefore be stored at +4 °C. 
5.3 Estimation of uncertainties 
Due to the intrinsic variation of measurement results, no study can entirely rule out 
degradation of materials, even in the absence of statistically significant trends. It is therefore 
necessary to quantify the potential degradation that could be hidden by the method 
repeatability, i.e. to estimate the uncertainty of stability. This means that, even under ideal 
conditions, the outcome of a stability study can only be that there is no detectable 
degradation within an uncertainty to be estimated.  
The uncertainties of stability during dispatch and storage were estimated, as described in 
[11] for each CRM. In this approach, the uncertainty of the linear regression line with a slope 
of zero was calculated. The uncertainty contributions usts and ults were calculated as the 
product of the chosen transport time/shelf life and the uncertainty of the regression lines as: 
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 Equation 5 
srel  relative standard deviation of all results of the stability study 
ti time elapsed at time point i 
t  mean of all ti   
ttt chosen transport time (1 week at 60 ºC) 
tsl chosen shelf life (24 months at 18 ºC) 
 
The following uncertainties were estimated: 
- usts,rel, the uncertainty of degradation during dispatch. This was estimated from the 
+60 °C studies. The uncertainty describes the possible change during a dispatch at 
+60 °C lasting for one week. 
- ults,rel, the stability during storage. This uncertainty contribution was estimated from 
the +4 °C studies.  
The results of these evaluations are summarised in Table 5. 
Table 5: Uncertainties of stability during dispatch and storage. usts,rel was calculated for 
a temperature of+ 60 °C and 1 week; ults,rel was calculated for a storage temperature of 
+4 °C and 24 months 
 usts ,rel 
[%] 
ults,rel 
[%] 
ERM-AC051 0.018 0.024 
ERM-AC053 0.065 0.124 
ERM-AC082 0.038 0.070 
 
As discussed for the homogeneity study, it is obvious that DSC overestimates the purity of 
the materials. This could lead to an overestimation of the stability of the compounds. If 
degradation would occur, it would most likely be an oxidative process, that would probably 
lead to degradation products which are more polar than the parent compounds. Such 
degradation products would probably not form solid solutions with the main component and 
would therefore be detectable by DSC. Due to this reason no further investigations on 
stability were done. 
After the certification study, the materials will be included in the JRC's regular stability 
monitoring programme, to control its further stability. 
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5.4 Additional confirmation of stability 
For the previous PAH CRMs, BCR-051R, BCR-053 and BCR-082R, no instability was 
detected over a period of 17 to 27 years. This confirms the finding of the long-term stability 
study. 
Since the characterisation exercise took longer than planned, it was decided to check the 
material stability beyond the established 24 months shelf life. This was done by comparative 
analysis of number vials of the CRM stored at the normal storage temperature (+4 °C) and 
number references samples (placed at -20 °C directly after the material processing). 
Degradation at -20 °C is assumed to proceed at a different speed than at +4 °C, so this 
comparison is a useful confirmation of stability.  
L5 performed two measurements each for all materials on samples stored at +4 and –20 °C, 
respectively. L6 performed 4 measurements on samples of ERM-AC082 from samples 
stored at +4 and -20 °C. All measurements were performed by qNMR and the results are 
shown in Table 6. 
Table 6: Purities of samples stored at +4 and at -20 °C as determined by qNMR. Given 
are average values and their expanded uncertainties for the respective temperatures. 
 L5 L6 
Purity -20 °C 
[g/g] 
Purity +4 °C 
[g/g] 
Purity -20 °C 
[g/g] 
Purity +4 °C 
[g/g] 
ERM-AC051 0.987 ± 0.010 0.988 ± 0.010 not analysed 
ERM-AC053 0.995 ± 0.010 0.995 ± 0.010 not analysed 
ERM-AC082 0.983 ± 0.010 0.983 ± 0.010 0.9821 ± 0.0030 0.9843 ± 0.0036  
 
The obtained results of the normal stock samples (stored at +4 °C) were compared with the 
values of the reference samples (stored at -20 °C) taking into account their uncertainties as 
stated by the laboratories. All purities for samples stored at +4 °C agreed with those of 
samples stored at -20 °C, demonstrating that no detectable change had occurred for 12 
years and that the uncertainties stated in Table 5 are still valid. 
 17 
6 Characterisation  
For the characterisation of the purity of the three materials, several laboratories provided 
measurements using a variety of methods.  
Two independent assessments of the purities were made: 
• the mass balance approach, where individual impurities are quantified and the purity 
is determined as 1 – sum of impurities 
• quantitative nuclear magnetic resonance (qNMR), which directly determines the purity 
of the target substance. 
6.1 Selection of participants 
Seven laboratories were selected based on criteria that comprised both technical 
competence and quality management aspects. Each participant was required to operate a 
quality system and to deliver documented evidence of its laboratory proficiency. Having a 
formal accreditation was not mandatory, but meeting the requirements of ISO/IEC 17025 or 
Good Manufacturing Practice (GMP) was obligatory. Where measurements are covered by 
the scope of accreditation/certification, the accreditation number is stated in the list of 
participants (Section 2).  
The laboratory code (e.g. L1) is a random number and does not correspond to the order of 
laboratories in Section 2.  
6.2 Study setup  
For measurements by gas chromatography (GC), high-performance liquid chromatography 
(HPLC) and DSC, each laboratory received two vials of CRM and was requested to provide 
six independent results per method, three per vial. For qNMR, each laboratory received two 
samples stored at +4 °C and performed 1-3 measurements per vial. Laboratories were 
instructed to identify and quantify purities with a peak area percentage above 0.3 % 
whenever possible. 
The vials for material characterisation were selected using a random stratified sampling 
scheme and covered the whole batch. The measurements had to be spread over at least two 
days to ensure intermediate precision conditions.  
6.3 Methods used 
The methods used for the mass-balance approach aimed at the quantification of organic 
impurities, inorganic impurities as well as residual solvents. In addition, quantitative NMR 
was used as a confirmation of the results of the mass balance. All methods used during the 
characterisation study are summarised in Annex D 
Organic impurities 
• GC utilizing flame ionisation detection (FID) and mass spectrometry (MS) detection. 
Columns of different polarity were used as well as two-dimensional GC (GCxGC-
FID). 
• HPLC with detection of absorption in the ultraviolet range (UV) employing different 
wavelengths for detection, different solvent mixtures and different gradients. 
Inorganic impurities 
• Inductively coupled plasma mass spectrometry (ICP-MS) and optical emission 
spectrometry (ICP-OES) after digestion was used for screening for 65 impurities 
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Residual solvents 
• GC should also show residual solvents. 
• DSC is also sensitive to residual solvents: Evaporation of solvent should lead to a 
disturbance of the heat flow curve, due to its evaporation enthalpy. 
Confirmation of identity and determination of purity by direct methods 
• Comparison of the retention times of the main compounds with retention times of 
commercial standards for the chromatographic methods was used as one method of 
confirming identity. 
• DSC directly measures the purity of substances as long as impurities do not form 
solid solutions with the main compound. 
• Elemental analysis (C, H, N, S) for a confirmation of the composition and detection of 
otherwise undetected impurities  
• qNMR calibrated with substances with traceable values provided a second 
independent estimate of the purity of the substances.  
All individual results of the participants, grouped per method are displayed in tabular and 
graphical form in Annex E.  
6.4 Confirmation of identity 
The identity of the substances is established by the processing, matching chromatographic 
signals, matching NMR signals and matching elemental composition. 
6.4.1 Processing 
The materials were derived from custom synthesis, which should result in the target 
substances as the main compound.  
6.4.2 Chromatography 
L3 used a commercial mixture of the 16 EPA PAHs to calibrate the HPLC and the GC x GC - 
FID method. The retention times of the main compounds in ERM-AC051, ERM-AC053 and 
ERM-AC053 matched those of the target compounds in the commercial mixture. 
6.4.3 Elemental composition 
Elemental analysis of hydrogen, nitrogen and carbon was used as proof of the identity of the 
compounds. Additionally, retention times observed in HPLC and GC matched with those of 
the respective compounds in calibrant mixtures. The results are summarised in Table 7. 
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Table 7: Results from elemental analysis. Errors are single standard deviations of 6 
measurements. LOD: Limit of detection 
 Mass fraction C 
[g/g] 
Mass fraction H 
[g/g] 
Mass fraction N 
[g/g] 
ERM-AC051 Theoretical 0.952 0.0479 0 
Found 0.945 ± 0.012 0.0486 ± 0.0007 < LOD (0.0007) 
ERM-AC053 Theoretical 0.9562 0.0438 0 
Found 0.955 ± 0.005 0.0454 ± 0.0011 < LOD (0.0007) 
ERM-AC082 Theoretical 0.9418 0.0582 0 
Found 0.937 ± 0.009 0.0589 ± 0.00078 < LOD (0.0007) 
 
Only trace amounts of other elements were found (see section 6.5.1). The elemental 
composition therefore matches the theoretical composition. 
6.4.4 NMR 
The NMR spectra of the main compounds matched the literature data for the target 
compounds in all laboratories. 
6.4.5 Conclusion 
NMR-data, retention times of liquid and two-dimensional gas-chromatography and overall 
elemental composition are in agreement with the assumed identity from the synthesis. The 
identity of the main compounds is therefore established beyond any doubt. 
6.5 Quantification of the purity 
6.5.1 Mass balance approach 
Accurate determination of the mass fraction of impurities for the chromatographic methods 
would require identification of all impurities, calibration (or at least knowledge of their relative 
molecular mass and sensitivity) and subsequent quantification. However, as it was not 
possible to identify the impurities, results were reported in area-percent for the 
chromatographic methods and mass fractions for the inorganic impurities.  
In the absence of reliable sensitivity factors for the impurities, area-fractions and mol-
fractions are converted into mass fractions using a conversion factor of one. This is justified 
because of the high purity of the main compound: uncertainty of the response factors for the 
individual impurities results in a large uncertainty for each of them. However, as the amounts 
of these impurities are low, this amounts to a high uncertainty on a low mass fraction and 
does not lead to a high uncertainty of the purity of the main compound. 
In order to obtain an overall estimate of the purity using the mass-balance approach, the 
impurities detected by GC-based methods, by HPLC-UV methods and the inorganic 
impurities were summed up and subtracted from unity.  
Organic impurities 
Some impurities detected by GC-MS could be tentatively identified as isomers and other 
structurally similar forms of the main compound or hydrogenated by-products of the 
synthesis. 
 20 
The assumption was made that GC-based methods would detect a different set of impurities 
than HPLC-UV, therefore the impurities detected by GC-based methods were added to the 
impurities detected by HPLC-UV to obtain the total of organic impurities. This assumption 
was based on the different separation principles of the methods. Obviously, this can only be 
an approximation, because it is likely that some impurities are detected by both methods. 
The finally stated purity of the PAHs was probably underestimated, due to the calculation 
approach chosen, but could be considered as best estimate that can be achieved with the 
available data. 
To estimate the mass fraction of impurities detected by a particular method (e.g. GC-based 
methods or HPLC-based methods), the following approach was taken: 
The different datasets, including the chromatograms provided by the different laboratories 
were considered, choosing the dataset that detected the largest number of impurities (not 
necessarily being identical with the largest mass fraction of impurities). The impurities 
detected in this dataset were then taken as the best estimate of the total impurities 
detectable by this method. In order to obtain an estimate for the uncertainty associated with 
the purity estimate, a symmetric uncertainty interval was chosen such that it would cover any 
value reported in other datasets using the same method. This uncertainty interval was then 
considered to follow a rectangular distribution and consequently converted into a standard 
uncertainty. This standard uncertainty was then used as an estimate of the uncertainty of the 
impurity determination with this particular method. The uncertainty of the total impurities was 
calculated as the square root of the sum of squares of the uncertainties of the different 
methods contributing to the total impurities. 
As a best estimate of impurities detectable by GC-based methods, GC-FID data was used. 
FID is generally considered to be the most universal detector with least differences in 
response to different compounds. Additionally, an analysis of the data and the 
chromatograms obtained revealed that overall GC-FID seemed to be able to detect the 
highest number of impurities (regarding the number of different impurities detected and the 
amount of impurities detected). GC-FID using a DB5 or DB17 column (i.e. columns of 
different polarity) did yield similar results. Therefore GC-FID data was used as a best 
estimate of all impurities that can be detected by GC-based methods. 
Each laboratory checked for absence of peaks by injecting pure solvent. 
Inorganic impurities 
Results of the elemental analysis of nitrogen and sulphur are summed up with the inorganic 
impurities as determined by ICP-MS and ICP-OES to obtain the total of inorganic impurities. 
The mass fractions of all detected elements were summed up. The standard uncertainty for 
this sum was estimated as 10 %. 
The sum of the limits of detection of the non-detected elements was taken as upper limit of 
the mass fraction of the not-detected elements. For the calculation, the mass fraction of all 
not-detected elements was set to zero. This is justified as the sum of the LODs of not 
detected elements was only 1/5 to 1/20 of the sum of the detected impurities. The standard 
uncertainty of this estimate was assumed to follow a rectangular distribution between zero 
and the sum of all LODs and was therefore obtained by dividing the sum of all LODs by √3. 
The final value for inorganic impurities was the sum of all detected impurities. The standard 
uncertainty of inorganic impurities was the combined uncertainty of the detected and not-
detected impurities as described above. 
 
Residual solvents 
Residual solvents were assessed only in a qualitative manner. Each compound was 
subjected to a DSC analysis starting at room temperature. Evaporation of solvent should 
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lead to a disturbance of the heat flow curve, due to its evaporation enthalpy. The observed 
heat flow curves of the three compounds were smooth up to their melting point, therefore 
solvent residues should not be present. 
This resulted in the following sets of data summarised in Table 8. 
Table 8: Summary of impurities as determined by different methods and combined 
purity following the mass-balance approach 
 
ERM-AC051 ERM-AC053 ERM-AC082 
Impurities 
[g/g] 
u 
[g/g] 
Impurities 
[g/g] 
u 
[g/g] 
Impurities 
[g/g] 
u 
[g/g] 
Impurities detected 
by GC-based 
methods 
0.0081 0.0006 0.0006 0.0003 0.0065 0.0007 
Impurities detected 
by HPLC-based 
methods 
0.0172 0.0056 0.0027 0.0016 0.0095 0.0040 
Inorganic impurities 0.0013 0.0001 0.0004 0.0001 0.0008 0.0001 
Total impurities 0.0266 0.0060 0.0037 0.0016 0.0168 0.0041 
Total purity 0.9734 0.0060 0.9963 0.0016 0.9832 0.0041 
 
6.5.2 Direct determination of purity 
DSC 
DSC measurements were used as additional confirmation, but not taken into account for the 
calculation of the certified value. DSC will not detect impurities that form solid solutions with 
the main component. As it was to be expected that most of the impurities would be 
structurally very similar by-products of the synthesis of the PAHs, it could be assumed that 
some impurities would not be detected by DSC. It was also to be expected that those 
impurities that DSC was able to detect, would also have been detected by the other methods 
applied. Comparing the DSC results with those of the other methods, it was quite apparent 
that DSC overestimated the purity of the PAHs. 
qNMR 
qNMR measurements were performed by four laboratories using different internal standards 
and solvents. The values of the qNMR measurements themselves are traceable, generally 
via NIST SRM 350b (benzoic acid) to the International System of Unit (SI). 
The values of the four laboratories agree within their respective uncertainties with the 
exception of the data from L1 for 6-methylchrysene, for which L1 found significantly lower 
values than obtained by mass balance and by the other qNMR measurements. The reason 
for this was elucidated by L6 which found that the purity values for 6-methylchrysene in 
deuterochloroform (CDCl3) are concentration dependent, with lower concentrations having a 
lower purity (a 100-fold dilution resulted in a 60 fold increase of impurities). This was 
explained by reaction of the 6-methylchrysene with impurities of CDCl3. This hypothesis was 
confirmed by mass spectrometric analysis of the solutions which found mono- and 
dichlorinated analogues of chrysene. Use of different batches of CDCl3, yielded the same 
result. This effect would explain the lower values found by L1. On the other hand, also L7 
used CDCl3 and found significantly higher results than L1. The explanation could be the 
concentrations that were used: L7 used 13 – 28 mg/mL whereas L1 used 7 – 10 mg/mL. The 
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at least 30 % higher concentration used by L7 might explain the absence of an effect, 
although both laboratories did not notice any effect of the mass fraction used. 
The data obtained using CDCl3 on ERM-AC082 cast doubt on results obtained at lower 
concentrations in this solvent. The results of L1 which were obtained at a lower concentration 
were therefore excluded from the purity assessment, whereas the results from L7, which 
found no effect of concentration even at the threefold concentration than used by L1 were 
retained. 
L5 and L6 used different solvents (D6-dimethylsulfoxide (DMSO)  D8-toluene), which are not 
affected by this effect. The results of all labs are summarised in Table 9.  
Table 9: Summary purities as determined by qNMR. Data from L1 for ERM-AC082 
were not used for value assignment. Coverage factors used were 2 (L1, L5 and 7) and 
2.26 (L6), respectively. 
 Purity ERM-AC051 Purity ERM-AC053 Purity ERM-AC082 
Purity 
[g/g] 
U 
[g/g] 
Purity 
[g/g] 
U 
[g/g] 
Purity 
[g/g] 
U 
[g/g] 
L1 0.9818 0.0100 0.9957  0.0080 0.9665 0.0110 
L5 0.9873 0.0099 0.9951 0.0099 0.9831 0.0098 
L6 Not analysed Not analysed 0.9843  0.0036 
L7 0.9868 0.0084 0.9943 0.0074 0.9825 0.0039 
 
The unweighted mean of the four laboratory means was used as the combined value for 
qNMR. For the uncertainty budgets submitted by the laboratories, it seems that the 
integration, together with the weighing of the samples are the main contributions of the 
measurement uncertainties. These factors are independent of one another and therefore 
reduce by the square root of the number of results averaged. The combined uncertainty was 
therefore estimated as 

 =  ! " # " $ " %&  Equation 6 
 uL1, uL5, uL6, uL7 standard uncertainties of the results of L1-L7 
Note that the denominator 3 in Equation 6 is the sensitivity coefficient of 1/3 , which comes 
from the division by 3 in averaging three results for each laboratory. The combined purity as 
determined by qNMR is shown in Table 10. 
 
Table 10: Combined purity as determined by qNMR 
Purity ERM-AC051 Purity ERM-AC053 Purity ERM-AC082 
Purity 
[g/g] 
U 
[g/g] 
Purity 
[g/g] 
U 
[g/g] 
Purity 
[g/g] 
U 
[g/g] 
0.9853 0.0054 0.9950 0.0053 0.9830 0.0037 
 
6.5.3 Combination of qNMR and mass-balance approach 
The results of the purity determined by the mass balance approach and by qNMR are shown 
in Figure 3. 
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Figure 3: Comparison of the results of the purity determination by mass balance and qNMR. 
Yellow: Mass fraction of the main compound. Red: impurities detected by HPLC. Green: 
impurities detected by GC. Orange: inorganic impurities. The error bar on the main 
compound is the expanded uncertainty (k=2).  
 
The results from the mass balance approach and from qNMR agree for all three materials 
within the respective uncertainties even if for ERM-AC051, the difference is slightly above 
0.01 g/g. Whether this is due to double counting of some impurities in the mass-balance 
approach, due to some undetected interference in qNMR or just random fluctuation as 
reflected in the uncertainties is not known. 
As the purity obtained by mass balance and by qNMR agree the purity of the three PAHs is 
equal to the average of the purities as determined by qNMR and the mass balance approach 
(Equation 7).  
' = 
"	)  Equation 7 
 wpurity combined purity of the starting material 
 wqNMR purity as determined by qNMR   
 wmass balance purity as determined by the mass balance approach 
The uncertainty was calculated according to Equation 8. Note that the denominator 2 in 
Equation 8 is the sensitivity coefficient of 1/2, which comes from the division by 2 in Equation 
7.  
 
The results are reported in Table 11: 
) = 


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	)+

   Equation 8 
 
uchar uncertainty of characterisation 
uqNMR  uncertainty derived from the purity determination by qNMR 
umass balance  uncertainty derived from the impurity determination 
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Table 11: Combined purities of the materials 
 Purity 
 
[g/g] 
Combined standard 
uncertainty uchar 
[g/g] 
Relative combined 
standard uncertainty 
uchar,rel 
[%] 
ERM-AC051 0.9794 0.0033 0.34 
ERM-AC053 0.9956 0.0016 0.16 
ERM-AC082 0.9831 0.0022 0.23 
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7 Value Assignment 
Certified values were assigned for the purity. 
Certified values are values that fulfil the highest standards of accuracy. Full uncertainty 
budgets in accordance with the 'Guide to the Expression of Uncertainty in Measurement' [3] 
were established.  
7.1 Certified values and their uncertainties 
The assigned uncertainty consists of uncertainties relating to characterisation, uchar (Section 
6), potential between-vial inhomogeneity, ubb (Section 4.1), and potential degradation during 
transport, usts, and long-term storage, ults (Section 5). The uncertainty related to 
inhomogeneity/degradation during transport was found to be negligible. These different 
contributions were combined to estimate the relative expanded uncertainty of the certified 
value (UCRM, rel) with a coverage factor k given as:  
2
rel char,
2
rel lts,
2
rel sts,
2
rel bb,rel CRM, uuuukU +++⋅=  Equation 9 
- uchar was estimated as described in Section 6  
- ubb was estimated as described in Section 4.1. 
- usts and ults were estimated as described in section 5.3 
 
A coverage factor k of 2 was applied, to obtain the expanded uncertainties. The certified 
values and their uncertainties are summarised in Table 12. 
For ERM-AC053 this resulted in an uncertainty interval exceeding a purity of 1 g/g. Therefore 
the upper limit of the uncertainty interval was truncated at 1 g/g, resulting in an asymmetric 
uncertainty interval. 
 
Table 12: Certified values and their uncertainties for ERM-AC051, ERM-AC053 and 
ERM-AC082. The asymmetric uncertainty interval of ERM-AC053 is based on a 
standard uncertainty of 0.0022 g/g. 
 Mass fraction 
[g/g] 
uchar,rel 
[%] 
ubb,rel 
[%] 
ults,rel 
[%] 
usts,rel 
[%] 
UCRM  
[g/g] 
ERM-AC051, 
benzo[a]pyrene 0.979 0.34 0.002 0.024 0.018 0.007 
ERM-AC053, 
indeno[1,2,3-cd]pyrene 0.996 0.16 0.061 0.12 0.065 
+ 0.004 
- 0.005 
ERM-AC082,  
6-methylchrysene 0.983 0.23 0.028 0.070 0.038 0.005 
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8 Metrological traceability and commutability 
8.1 Metrological traceability  
Identity 
The known synthetic route should result in the substances as the main compound. This 
assumption was confirmed by agreement of the NMR spectra with literature data, agreement 
of the elemental composition with the theoretical composition as well as the agreement of the 
retention time of the main compound with the retention times of standard solutions. 
Therefore, the identity of the substances is established beyond any doubt. 
Quantity value 
The purity values have been obtained by a combination of subtraction of the sum of 
impurities from unity and direct quantification by qNMR. The sum of impurities as such is not 
a value traceable to the International System of Units (SI), as it was not possible to identify 
and calibrate each measurement for the individual impurities. Still, the purity of the 
compounds can be considered SI traceable, as the fraction of impurities was small and 
associated with a conservative uncertainty estimate. 
The values by qNMR are traceable to the SI by the traceability of the standards used for 
quantification. 
The purity values are therefore SI traceable, as they are combinations of two SI traceable 
values. 
8.2 Commutability 
Many measurement procedures include one or more steps which select specific (or specific 
groups of) analytes from the sample for the subsequent whole measurement process. Often 
the complete identity of these 'intermediate analytes' is not fully known or taken into account. 
Therefore, it is difficult to mimic all analytically relevant properties of real samples within a 
CRM. The degree of equivalence in the analytical behaviour of real samples and a CRM with 
respect to various measurement procedures (methods) is summarised in a concept called 
'commutability of a reference material'. There are various definitions that define this concept. 
For instance, the CLSI Guideline C53-A [12] recommends the use of the following definition 
for the term commutability: 
"The equivalence of the mathematical relationships among the results of different 
measurement procedures for an RM and for representative samples of the type intended 
to be measured." 
The commutability of a CRM defines its fitness for use and is therefore a crucial 
characteristic when applying different measurement methods. When the commutability of a 
CRM is not established, the results from routinely used methods cannot be legitimately 
compared with the certified value to determine whether a bias does not exist in calibration, 
nor can the CRM be used as a calibrant.  
PAH calibrants are normally prepared by dissolving the solid substances in a solvent or they 
are directly purchased as solutions from commercial suppliers. There is no reason to assume 
that a solution prepared from ERM-AC051, ERM-AC053 or ERM-AC082 would behave 
differently from solutions prepared from solid PAHs of other suppliers or that it would behave 
differently from a commercially available calibrant solution. Therefore, ERM-AC051, ERM-
AC053 and ERM-AC082 are considered commutable to commercially available calibrants or 
preparations in the individual laboratory. 
 27 
9 Instructions for use 
9.1 Safety information 
The three substances are classified as hazardous. Specific hazards and safety measures are 
listed in the safety data sheets (SDS) available at https://crm.jrc.ec.europa.eu. 
9.2 Storage conditions 
The materials should be stored at +4 °C (between +1 and +9 °C) in the dark.  
Please note that the European Commission cannot be held responsible for changes that 
happen during storage of the material at the customer's premises, especially for opened 
vials. 
9.3 Minimum sample intake 
The minimum sample intake for all materials is 1 mg. 
It is recommended to use an appropriate balance in order to minimise weighing uncertainties 
when weighing such small quantities. 
9.4 Use of the certified value 
The main purpose of this material is for instrument calibration. This material can also be used 
to assess own calibrants. 
For assessing own calibrants, the measured values of the CRMs are compared with the 
certified values following a procedure described in an ERM application note [13]. The 
procedure is described here in brief 
• Calculate the absolute difference between the mean measured value and the certified 
value ( m∆ ) 
• Combine the measurement uncertainty ( mu ) with the uncertainty of the certified value 
( CRMu ): 22 CRMm uuu +=∆  
• Calculate the expanded uncertainty ( ∆U ) from the combined uncertainty ( ∆u ) using a 
coverage factor of two (k = 2), corresponding to a confidence interval of 
approximately 95 % 
• If ∆≤∆ Um  then there is no significant difference between the measurement result 
and the certified value, at a confidence level of about 95 %. 
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Annex A: Results of the homogeneity measurements 
Table A.1: Homogeneity data for ERM-AC051 
 Purity [mol-%] 
Vial no. Replicate 1 Replicate 2 Replicate 3 
40 99.88 99.87 99.87 
79 99.88 99.87 99.87 
115 99.88 99.87 99.87 
226 99.87 99.88 99.87 
263 99.88 99.88 99.88 
328 99.87 99.87 99.87 
405 99.87 99.88 99.87 
494 99.87 99.87 99.87 
598 99.87 99.88 99.88 
617 99.89 99.87 99.87 
672 99.88 99.87 99.88 
760 99.88 99.88 99.87 
784 99.87 99.87 99.87 
863 99.88 99.86 99.86 
913 99.89 99.87 99.87 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table A.2: Homogeneity data for ERM-AC053 
 Purity [mol-%] 
Vial no. Replicate 1 Replicate 2 
34 99.48 99.6 
118 99.72 99.62 
220 99.52 99.78 
269 99.62 99.48 
382 99.68 99.61 
465 99.42 99.66 
572 99.72 99.58 
710 99.51 99.58 
861 99.72 99.72 
960 99.8 99.85 
 
Table A.3: Homogeneity data of ERM-AC082 
 Purity [mol-%] 
Vial no. Replicate 1 Replicate 2 
1 99.72 99.68 
136 99.7 99.72 
249 99.7 99.64 
319 99.74 99.58 
413 99.66 99.73 
503 99.71 99.63 
616 99.71 99.66 
840 99.76 99.7 
937 99.74 99.75 
741 99.69 99.55 
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Annex B: Results of the short-term stability studies 
 
Figure B.1: Short-term stability graph for ERM-AC051 
 
 
Figure B.2: Short-term stability graph for ERM-AC053 
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Figure B.3: Short-term stability graph for ERM-AC082 
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Annex C: Results of the long-term stability studies 
 
 
Figure C.1: Long-term stability graph for ERM-AC051, test temperature 4 ºC 
 
 
Figure C.2: Long-term stability graph for ERM-AC053, test temperature 4 ºC 
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Figure C.3: Long-term stability graph for ERM-AC082, test temperature 4 ºC 
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Annex D: Summary of methods used in the characterisation study 
Laboratory code - 
Method 
Description 
L1 - GC-FID DB5 Gas chromatography with flame ionisation detection, using a DB5 column 
Column dimensions (length x diameter x film thickness): 60 m x 0.32 mm x 0.25 µm 
Carrier gas: H2, 2 mL/min 
Temperature programme: 1 min @ 100 ºC 
  increase to 280 ºC with 50 ºC/min 
  55 min @ 280 ºC 
Detector temperature: 300 ºC 
L1 - GC-FID DB17 Gas chromatography with flame ionisation detection, using a DB17 column 
Column dimensions (length x diameter x film thickness): 30 m x 0.32 mm x 0.25 µm 
Carrier gas: H2, 2 mL/min 
Temperature programme: 1 min @ 100 ºC 
  increase to 280 ºC with 50 ºC/min 
  55 min @ 280 ºC 
Detector temperature: 300 ºC 
L3 – GCxGC FID Comprehensive two-dimensional gas chromatography using flame ionization detection 
First dimensional column: RTX-1 (30 m x 0.32 mm x 0.25 µm) 
Second dimensional column: BPX50 (1.5 m x 0.10 mm x 0.1 µm) 
Carrier gas: H2, 0.4 mL/min 
Temperature programme: 2 min @ 40 ºC 
  increase to 100 ºC with 10 ºC/min 
  1 min @ 100 ºC 
  increase to 330 ºC with 3 ºC/min 
  10 min @ 330 ºC 
Sample intake: 2 – 5 mg 
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Laboratory code - 
Method 
Description 
L1 - GC-MS DB5MS 
The results coded L1-
GC-MS-DB5MS and L1 - 
GC-MS DB17 have been 
obtained on different 
instruments, but using 
the same sample 
solution. They are 
considered independent, 
as different instruments 
and columns were used. 
Gas chromatography with mass spectrometric detection, using a DB5MS column 
Column dimensions (length x diameter x film thickness): 30 m x 0.25 mm x 0.25 µm 
Carrier gas: He, 1 mL/min 
Temperature programme: 3 min @ 80 ºC 
  increase to 120 ºC with 30 ºC/min 
  increase to 310 ºC with 5 ºC/min 
  10 min @ 310 ºC 
Injector temperature: 80 ºC on column 
Detector temperature: 220 ºC 
L1 - GC-MS DB17 
The results coded L1-
GC-MS-DB5MS and L1 - 
GC-MS DB17 have been 
obtained on different 
instruments, but using 
the same sample 
solution. They are 
considered independent, 
as different instruments 
and columns were used. 
Gas chromatography with mass spectrometric detection, using a DB17 column 
Column dimensions (length x diameter x film thickness): 60 m x 0.25 mm x 0.25 µm 
Carrier gas: He, 2 mL/min 
Temperature programme: 3 min @ 80 ºC 
  increase to 120 ºC with 30 ºC/min 
  increase to 310 ºC with 5 ºC/min 
  10 min @ 310 ºC 
Injector temperature: 80 ºC on column 
Detector temperature: 220 ºC 
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Laboratory code - 
Method 
Description 
L4 - GC-MS 
DB17MS 
Gas chromatography with mass spectrometric detection, using a DB17MS column 
Column dimensions (length x diameter x film thickness): 30 m x 0.25 mm x 0.25 µm 
Carrier gas: He, 1.5 mL/min 
Temperature programme: 1.5 min @ 80 ºC 
  increase to 260 ºC with 10 ºC/min 
  increase to 320 ºC with 3 ºC/min 
  10 min @ 320 ºC  
Injector temperature (PTV injection): 80 ºC (0.01 min), increase to 330 ºC with 8 ºC/s, hold 5 min 
Ion source temperature: 250 ºC 
Sample intake: 2 – 5 mg 
L1 - HPLC-UV x nm High performance liquid chromatography with UV detection at x=254, 270, 274, 285, 294 nm, using an Ultrasep 
ES PAH column. 6-methylchrysene  
Column dimensions (length x diameter): 125 mm x 2 mm 
Flow: 0.25 mL/min 
Column temperature: 25 ºC 
Solvent: Acetonitirile/chloroform 10:1 (v:v) 
Gradient: time (min) acetonitrile (%) water (%) 
 0 - 22 80  20 
 22 - 26 from 80 to 90 from 20 to 10 
 26 - 60 90  10  
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Laboratory code - 
Method 
Description 
L2 - HPLC-UV 254 
nm 
High performance liquid chromatography with UV detection at 254 nm, using a Nacalai Tesque Cosmosil 5 
PYE column 
Column dimensions (length x diameter): 150 mm x 4.6 mm 
Column temperature: 30 ºC 
Gradient: time (min) water (%)  methanol (%) 
 0 - 2 20  80 
 2 – 10 from 20 to 0  from 80 to 100   
 10-25 0  100  
L3 - HPLC-UV 250 
nm 
High performance liquid chromatography with UV detection at 250 nm, using a Vydac 201TP5415 column 
Column temperature: 35 ºC 
Solvent: Acetonitirile/water 
Gradient: time (min) acetonitrile (%) water (%) 
 0 - 20 from 50 to 100 from 50 to 0 
 20 - 29 100  0 
Sample intake: 5 mg 
L4 - HPLC-UV 254 
nm 
High performance liquid chromatography with UV detection at 254 nm, using a Supelcosil LC-PAH column 
Column dimensions (length x diameter): 150 mm x 4.6 mm 
Particle size: 5 µm 
Flow: 1.5 mL/min 
Gradient: time (min) water:acetonitrile (90:10 v:v) (%) acetonitrile (%) 
 0 - 5 60   40 
 5 – 30 from 60 to 0   from 40 to 100 
 30 - 45 0   100  
Sample intake: 2 – 5 mg 
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Laboratory code - 
Method 
Description 
L1 - DSC Differential scanning calorimetry 
0.7 to 1.7 mg samples sealed into 50 µL aluminium pans 
L4 - DSC Differential scanning calorimetry 
Sample intake 1.16 – 1.8 mg 
L1 - ICP-MS Measurement of inorganic impurities (65 trace elements) by ICP-MS (with collision cell in He-mode) after high 
pressure microwave digestion using nitric acid 
Temperature programme: time (min) temperature (ºC) 
  16  20 - 160  
  15  160 - 250 
  45  250  
Starting pressure: 50 bar, increasing to 100 bar at 250 ºC 
L1 - ICP-OES Measurement of S and P by ICP-OES after high pressure microwave digestion using nitric acid 
Temperature programme: time (min) temperature (ºC) 
  16  20 - 160  
  15  160 - 250 
  45  250  
Starting pressure: 50 bar, increasing to 100 bar at 250 ºC 
L1 – COMB-COND Determination of H, C, N using a Elementar vario MACRO (Elementar, DE) based on catalytic combustion of 
the sample with oxygen at 960 °C, separation of the reaction gases with absorption columns and quantification 
via thermal conductivity detection. 
L1 – COMB-UVF Determination of S with a TN/TC 3000b (Thermo Electron, Waltham, US): Samples were dissolved in toluene, 
were combusted and the S content is quantified by UV fluorescence. 
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Laboratory code - 
Method 
Description 
L1-qNMR Dissolution of 10 mg substance and 10 mg internal standard were dissolved in 1.0 and 1.5 mL CDCl3. 
Internal standard: 1,3,5 trioxane (Merck 8.21190.0100)  assayed in-house by qNMR against NIST SRM 350a 
(bezoic acid) 
Instrument and settings: Bruker Avance 600: spectral window: 9615 Hz; relaxation delay 60 s; excitation pulse: 
7 µs 
Evaluated line: 1H resonance frequency at 600.20 MHz 
L5-qNMR Dissolution of 10-15 mg substance and 8-10 mg internal standard were dissolved in 1.4 mL (CD3)2SO from 
Euriso-top, Saarbruecken (DE). 
Internal standard: CRM for qNMR TraceCert®: ethyl 4-(dimethylamino)benzoate (Fluka 42582) 
(benzo[a]pyrene)/ 1,2,4,5 tetramethylbenzene (Fluka 74658) (indeno(1,2,3-cd]pyrene; 6-methylchrysene)  
Instrument and settings: Bruker Avance III 600: spectral window: 14423 Hz (benzo[a]pyrene indeno(1,2,3-
cd]pyrene)/12335 Hz (6-methylchrysene); relaxation delay 1 s (benzo[a]pyrene indeno(1,2,3-cd]pyrene)/ 30 s 
(6-methylchrysene); excitation pulse: 12 µs 
L6-qNMR Dissolution of 8 mg substance and 3 mg internal standard were dissolved in 1 mL C7D8 (deuterotoluene) from 
Sigma-Aldrich. 
Internal standard: CRM for qNMR TraceCert®: dimethyl terephthalate (Fluka 070328)  
Instrument and settings: Bruker Avance 600: spectral width: 20 ppm; relaxation delay 30 s 
L7-qNMR Dissolution of 20 mg substance and 10 mg internal standard in 0.7, 1.0 and 1.4 mL CD2Cl2 (benzo(a)pyrene, 
indeno(1,2,3-cd]pyrene) or CDCl3 (6-methylchrysene) 
Internal standard: CRM for qNMR TraceCert®: 1,2,4,5-tetramethylbenzene  (Sigma 74658) 
Instrument and settings: Bruker Ascend 400: spectral window 812.8 Hz; relaxation delay 1 s 
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Annex E: Results of the characterisation measurements 
Table E.1: Summary of data for ERM-AC051. Values in bold   
were used as estimate for purity for the respective methods. 
Laboratory code - Method Mean purity 
[g/g] 
Standard deviation 
[g/g] 
L1 - HPLC-UV 254 nm1) 0.98941 0.00008 
L1 - HPLC-UV 270 nm1) 0.98837 0.00005 
L1 - HPLC-UV 285 nm1) 0.99260 0.00014 
L2 - HPLC-UV 254 nm 0.98892 0.00029 
L3 - HPLC-UV 250 nm 0.99033 0.00015 
L4 - HPLC-UV 254 nm 0.98285 0.00130 
L1 - GC-MS DB5MS 0.99550 0.00026 
L1 - GC-MS DB17 0.99190 0.00030 
L3 - GCxGC 0.99318 0.00041 
L4 - GC-MS DB17MS 0.99562 0.00015 
L1 - GC-FID DB5 0.99187 0.00006 
L1 - GC-FID DB17 0.99293 0.00046 
L1 – inorganic2) 0.99866 0.00014 
L1 - DSC 0.99907 0.00021 
L4 - DSC 0.99874 0.00004 
L1-qNMR 0.98188 0.00679 
L5-qNMR 0.98728 0.00206 
L7-qNMR 0.98679 0.00385 
1) The three results with laboratory code 4 have been obtained in the same analytical runs, using a diode array detector. Results from three selected wavelengths of these runs 
have been reported. They are not considered as independent results. 
2) purity considering only inorganic impurities  
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Table E.2: HPLC data for ERM-AC051. Given are averages and standard deviations of the area percentages of six determinations. The column 
in bold was used as estimate for purity for HPLC methods. 
Laboratory 
 
L1 - HPLC-UV  
254 nm 
L1 - HPLC-UV  
270 nm 
L1 - HPLC-UV  
285 nm 
L2 - HPLC-UV  
254 nm 
L3 - HPLC-UV  
250 nm 
L4 - HPLC-UV  
254 nm 
Main peak % 98.941 ± 0.008 98.837 ± 0.005 99.260 ± 0.014 98.892 ± 0.029 99.033 ± 0.015 98.285 ± 0.13 
Impurity 1 % 0.028 ± 0.004 0.037 ± 0.005 0.040 ± 0.000 0.092 ± 0.008 0.087 ± 0.006 0.202 ± 0.042 
Impurity 2 % 0.085 ± 0.010 0.053 ± 0.008 0.023 ± 0.005 1.013 ± 0.030 0.740 ± 0.017 0.092 ± 0.022 
Impurity 3 % 0.020 ± 0.000 0.020 ± 0.000 0.042 ± 0.004  0.138 ± 0.021 0.325 ± 0.087 
Impurity 4 % 0.110 ± 0.000 0.307 ± 0.005 0.515 ± 0.005   0.035 ± 0.005 
Impurity 5 % 0.705 ± 0.010 0.610 ± 0.011 0.075 ± 0.005   0.130 ± 0.000 
Impurity 6 % 0.082 ± 0.004 0.103 ± 0.005 0.010 ± 0.000   0.780 ± 0.017 
  
Figure E.1: Example chromatogram of  'L4 HPLC-UV 254 nm'. These data were used as best estimate of impurities detectable by HPLC-
UV-methods for ERM-AC051. 
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Table E.3: GC data for ERM-AC051. Given are averages and standard deviations of the area percentages of six determinations. The column in 
bold was used as estimate for purity for GC methods. 
Laboratory L1 - GC-FID DB5 L1 - GC-FID DB17 L1 - GC-MS DB5MS L1 - GC-MS DB17 L3 - GCxGC FID L4 - GC-MS 
DB17MS 
Main peak % 99.187 ± 0.006 99.293 ± 0.047 99.550 ± 0.026 99.190 ± 0.030 99.318 ± 0.041 99.562 ± 0.015 
Impurity 1 % 0.125 ± 0.003 0.117 ± 0.007 0.053 ± 0.005 0.123 ± 0.005 0.093 ± 0.008 0.307 ± 0.008 
Impurity 2 % 0.133 ± 0.001 0.146 ± 0.009 0.070 ± 0.006 0.148 ± 0.008 0.085 ± 0.004 0.128 ± 0.008 
Impurity 3 % 0.527 ± 0.004 0.425 ± 0.047 0.327 ± 0.018 0.543 ± 0.027 0.327 ± 0.023  
Impurity 4 % 0.018 ± 0.001 0.013 ± 0.002   0.179 ± 0.018  
Impurity 5 % 0.011 ± 0.001 0.006 ± 0.002     
 
Figure E.2: Example chromatogram of  'L1 GC-FID DB5'. These data were used as best estimate of impurities detectable by GC-methods 
for ERM-AC051. 
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Table E.4: Average results by DSC and qNMR for ERM-AC051. Error for DSC is the standard deviation of six determinations. Errors for qNMR 
are expanded uncertainties (k=2) 
Laboratory L1 - DSC L4 - DSC L1 - qNMR L5 - qNMR L7 - qNMR 
Purity % 99.907 ± 0.021 99.87378 99.19 ± 0.98 98.73 ± 0.49 98.68 ± 0.84 
 
 
Figure E.3: Example 1H NMR spectrum (L5). 
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Table E.5: Data for the inorganic impurities of ERM-AC051 
Inorganic impurities Reported 
impurities 
[g/g] 
Impurity value 
used in 
calculations 
[g/g] 
Standard 
uncertainty 
[g/g] 
S (S analyser)  0.00104 Not used Not used 
Detected 15 elements including S (ICP-OES, ICP-MS) 0.00134 0.00134 0.00013 
Sum of not detected 53 elements [g/g] (ICP-OES, ICP-MS) 0.00007 0.00000 0.00004 
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Table E.6: Summary of data for ERM-AC053. Values in bold   
were used as estimate for purity for the respective methods 
Method Mean purity [g/g] Standard deviation [g/g]  
L1 - HPLC-UV 254 nm2) 0.99750 0.00021 
L1 - HPLC-UV 274 nm2) 0.99727 0.00021 
L1 - HPLC-UV 294 nm2) 0.99812 0.00018 
L2  -HPLC-UV 254 nm 1.00000 n.d. 1) 
L3 - HPLC-UV 250 nm 0.99780 0.00032 
L4 - HPLC-UV 254 nm 0.99683 0.00040 
L1 - GC-MS DB5MS3) 0.99985 0.00008 
L1 - GC-MS DB173) 1.00000 n.d. 1) 
L3 - GCxGC 0.99838 0.00040 
L4 - GC-MS DB17MS 1.00000 n.d. 1) 
L1 - GC-FID DB5 0.99943 0.00040 
L1 - GC-FID DB17 0.99943 0.00019 
L1 - inorganic4) 0.99960 0.00006 
L1 - DSC 0.99470 0.00083 
L4 - DSC 0.99630 0.00094 
L1 - qNMR 0.99565 0.00295 
L5 - qNMR 0.99505 0.00102 
L7 - qNMR 0.99429 0.00319 
1) n.d. not defined either because all results were 1.0000 or because only 2 measurements were performed (l5-qNMR) 
2) The three results with laboratory code 1 have been obtained in the same analytical runs, using a diode array detector. Results from three selected wavelengths of these runs 
have been reported. They are not considered as independent results. 
4) Purity considering only inorganic impurities 
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Table E.7: HPLC data for ERM-AC053. Given are averages and standard deviations of the area percentages of six determinations. The column 
in bold was used as estimate for purity for HPLC methods. 
Laboratory 
 
L1 - HPLC-UV  
254 nm 
L1 - HPLC-UV  
274 nm 
L1 - HPLC-UV  
294 nm 
L2 - HPLC-UV  
254 nm 
L3 - HPLC-UV  
250 nm 
L4 - HPLC-UV  
254 nm 
Main peak % 99.75 ± 0.028 99.727 ± 0.021 99.812 ± 0.018 100.000 ± 0.000 99.780 ± 0.032 99.683 ± 0.040 
Impurity 1 % 0.010 ± 0.000 0.022 ± 0.004 0.010 ± 0.000  0.013 ± 0.003 0.024 ± 0.017 
Impurity 2 % 0.010 ± 0.000 0.008 ± 0.004 0.022 ± 0.004  0.054 ± 0.012 0.085 ± 0.026 
Impurity 3 % 0.030 ± 0.006 0.010 ± 0.000 0.087 ± 0.008  0.043 ± 0.013 0.010 ± 0.000 
Impurity 4 % 0.107 ± 0.012 0.040 ± 0.006 0.040 ± 0.011  0.016 ± 0.001 0.132 ± 0.050 
Impurity 5 % 0.053 ± 0.010 0.010 ± 0.000 0.020 ± 0.000  0.101 ± 0.026 0.022 ± 0.004 
Impurity 6 % 0.023 ± 0.005 0.020 ± 0.000    0.048 ± 0.017 
Impurity 7 %  0.082 ± 0.012    0.015 ± 0.005 
Impurity 8 %  0.050 ± 0.006     
Impurity 9 %  0.020 ± 0.010     
 
Figure E4 Example chromatogram of 'L1 HPLC-UV 274 nm'. These data were used as best estimate of impurities detectable by HPLC-
UV-methods for ERM-AC053. 
 
 49 
Table E.8: GC data for ERM-AC053. Given are averages and standard deviations of the area percentages of six determinations. The column in 
bold was used as estimate for purity for GC methods. 
Laboratory L1 - GC-FID DB5 L1 - GC-FID DB17 L1 - GC-MS DB5MS L1 - GC-MS DB1) L3 - GCxGC FID L4 - GC-MS DB17MS 
Main peak % 99.943 ± 0.040 99.943 ± 0.019 99.985 ± 0.008 100.000 ± 0.000 99.838 ± 0.04 100.000± 0.000 
Impurity 1 % 0.007 ± 0.004 0.007 ± 0.003 0.006 ± 0.003  0.068 ± 0.026  
Impurity 2 % 0.003 ± 0.002 0.010 ± 0.005 0.012 ± 0.004  0.044 ± 0.017  
Impurity 3 % 0.016 ± 0.011 0.012 ± 0.004   0.049 ± 0.014  
Impurity 4 % 0.006 ± 0.004 0.005 ± 0.003     
Impurity 5 % 0.020 ± 0.016 0.017 ± 0.007     
Impurity 6 % 0.006 ± 0.005 0.007 ± 0.003     
 
  
Figure E.5: Example chromatogram of 'L1 GC-FID DB5'. These data were used as best estimate of impurities detectable by GC-methods 
for ERM-AC053. 
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Table E.9: Average results by DSC and qNMR for ERM-AC053. Error for DSC is the standard deviation of six determinations. Errors for qNMR 
are expanded uncertainties (k=2) 
Laboratory L1 - DSC L4 - DSC L1 - qNMR L5 – qNMR L7 – qNMR 
Purity % 99.470 ± 0.083 99.630 ± 0.094 99.57 ± 1.00 99.51 ± 1.00 99.43 ± 0.74 
 
 
Figure E.6: Example 1H NMR spectrum (L5). 
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Table E.10: Data for the inorganic impurities of ERM-AC053 
Inorganic impurities Reported 
impurites 
[g/g] 
Impurity value 
used in 
calculations 
[g/g] 
Standard 
uncertainty 
[g/g] 
S (S analyser) [g/g] 0.00003 Not used Not used 
Detected 12 elements including S (ICP-OES, ICP-MS) 0.00040 0.00040 0.00004 
Sum of not detected 55 elements [g/g] (ICP-OES, ICP-MS) 0.00007 0.00000 0.00004 
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Table E.11: Summary of data for ERM-AC082. Values in bold   
were used as estimate for purity for the respective methods 
Method Mean purity 
[g/g] 
Standard deviation 
[g/g] 
L1 - HPLC-UV 254 nm1) 0.99045 0.00001 
L1 - HPLC-UV 270 nm1) 0.99380 0.00020 
L2 - HPLC-UV 254 nm 0.99742 0.00021 
L3 - HPLC-UV 250 nm 0.98658 0.00081 
L4 - HPLC-UV 254 nm 0.99025 0.00018 
L1 - GC-MS DB5MS2) 0.99690 0.00028 
L1 - GC-MS DB172) 0.99732 0.00056 
L4 - GC-MS DB17MS 0.99640 0.00015 
L3 - GCxGC 0.99628 0.00083 
L1 - GC-FID DB5 0.99350 0.00013 
L1 - GC-FID DB17 0.99477 0.00039 
L1 – inorganic2) 0.99920 0.00008 
L1 - DSC 0.99648 0.00051 
L4 - DSC 0.99690 0.00040 
L1 – qNMR 3) 0.96645 0.00812 
L5 - qNMR 0.98318 0.00433 
L6 - qNMR 0.98325 0.00228 
L7 - qNMR 0.98249 0.00100 
1) The two results with laboratory code 1 have been obtained in the same analytical runs, using a diode array detector. Results from two selected wavelengths of these runs 
have been reported. They are not considered as independent results. 
2) purity considering only inorganic impurities 
3) Not used because of reaction of methylchrysene with impurities in CDCl3 
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Table E.12: HPLC data for ERM-AC082. Given are averages and standard deviations of the area percentages of six determinations. The 
column in bold was used as estimate for purity for HPLC methods. 
Laboratory 
 
L1 - HPLC-UV  
254 nm 
L1 - HPLC-UV  
270 nm 
L2 - HPLC-UV  
254 nm 
L3 - HPLC-UV  
250 nm 
L4 - HPLC-UV  
254 nm 
Main peak % 99.045 ± 0.012 99.38 ± 0.02 99.742 ± 0.021 98.658 ± 0.081 99.025 ± 0.018 
Impurity 1 % 0.010 ± 0.000 0.018 ± 0.004 0.117 ± 0.02 0.054 ± 0.005 0.035 ± 0.005 
Impurity 2 % 0.010 ± 0.000 0.010 ± 0.000 0.038 ± 0.008 0.105 ± 0.009 0.118 ± 0.004 
Impurity 3 % 0.040 ± 0.000 0.020 ± 0.000 0.052 ± 0.012 0.170 ± 0.014 0.240 ± 0.006 
Impurity 4 % 0.025 ± 0.037 0.082 ± 0.004 0.052 ± 0.013 0.380 ± 0.009 0.16 ± 0.006 
Impurity 5 % 0.127 ± 0.065 0.063 ± 0.005  0.198 ± 0.02 0.060 ± 0.000 
Impurity 6 % 0.292 ± 0.155 0.140 ± 0.009  0.049 ± 0.007 0.010 ± 0.000 
Impurity 7 % 0.120 ± 0.035 0.050 ± 0.000  0.233 ± 0.020 0.172 ± 0.013 
Impurity 8 % 0.042 ± 0.016 0.205 ± 0.016  0.157 ± 0.023 0.178 ± 0.008 
Impurity 9 % 0.057 ± 0.114 0.010 ± 0.000    
  
Figure E.7: Example chromatogram of 'L1 HPLC-UV 254 nm'. These data were used as best estimate of impurities detectable by HPLC-
UV-methods for ERM-AC082. 
 54 
Table E.13: GC data for ERM-AC082. Given are averages and standard deviations of the area percentages of six determinations. The column 
in bold was used as estimate for purity for GC methods. 
Laboratory L1 - GC-FID DB5 L1 - GC-FID DB17 L1 - GC-MS DB5MS L1 - GC-MS DB17 L3 - GCxGC FID L4 - GC-MS DB17MS 
Main peak % 99.35 ± 0.013 99.477 ± 0.039 99.69 ± 0.028 99.732 ± 0.056 99.628 ± 0.083 99.64 ± 0.015 
Impurity 1 % 0.083 ± 0.005 0.078 ± 0.004 0.032 ± 0.004 0.062 ± 0.010 0.061 ± 0.014 0.198 ± 0.008 
Impurity 2 % 0.215 ± 0.005 0.215 ± 0.005 0.085 ± 0.010 0.158 ± 0.021 0.165 ± 0.035 0.115 ± 0.005 
Impurity 3 % 0.110 ± 0.006 0.045 ± 0.023 0.070 ± 0.011 0.048 ± 0.029 0.059 ± 0.017 0.048 ± 0.004 
Impurity 4 % 0.060 ± 0.000 0.043 ± 0.008 0.035 ± 0.005  0.086 ± 0.027  
Impurity 5 % 0.030 ± 0.009 0.012 ± 0.004 0.088 ± 0.012    
Impurity 6 % 0.153 ± 0.012 0.125 ± 0.018     
 
 
Figure E.8: Example chromatogram of  'L1 GC-FID DB5'. These data were used as best estimate of impurities detectable by GC-methods 
for ERM-AC082. 
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Table E.14: Average results by DSC and qNMR for ERM-AC082. Error for DSC is the standard deviation of six determinations. Errors for qNMR 
are expanded uncertainties (k=2) 
Laboratory L1 - DSC L4 - DSC L1 - qNMR L5 – qNMR L6 – qNMR L7 – qNMR 
Purity % 99.648 ± 0.051 99.690 ± 0.040 96.65 ± 0.97 98.32 ± 0.98 98.325 ± 0.36 98.25 ± 0.39 
 
 
Figure E.9: Example 1H NMR spectrum (L5). 
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Table E.15: Data for the inorganic impurities of ERM-AC082 
Inorganic impurities Reported 
impurites 
[g/g] 
Impurity value 
used in 
calculations 
[g/g] 
Standard 
uncertainty 
[g/g] 
S (S analyser) 0.00039 Not used Not used 
Detected 18 elements including S (ICP-OES, ICP-MS) 0.00080 0.00080 0.00008 
Sum of not detected 50 elements [g/g] (ICP-OES, ICP-MS) 0.00006 0.00000 0.00004 
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